Diabetic neuropathies: A statement by the American Diabetes Association

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 956-962

  Boulton, Andrew J M ^a,b   Vinik, Arthur I ^c,j   Arezzo, Joseph C ^d   Bril, Vera ^e   Feldman, Eva L ^f   Freeman, Roy ^g   Malik, Rayaz A ^a   Maser, Raelene E ^h   Sosenko, Jay M ^b   Ziegler, Dan ⁱ  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF DELAWARE   (United States)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j Strelitz Diabetes Center   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CITALOPRAM; DULOXETINE; GABAPENTIN; IMIPRAMINE; NORADRENALIN UPTAKE INHIBITOR; OXYCODONE; PAROXETINE; PREGABALIN; SEROTONIN; TOPIRAMATE; TRAMADOL;

AUTONOMIC NEUROPATHY; BLADDER DYSFUNCTION; CALLUS; CONSTIPATION; DEMYELINATING NEUROPATHY; DIABETIC NEPHROPATHY; DIARRHEA; DROWSINESS; ELECTROPHYSIOLOGY; ENTEROPATHY; EXERCISE; FATIGUE; FOOD AND DRUG ADMINISTRATION; FOOT MALFORMATION; FOOT ULCER; GASTROINTESTINAL ENDOSCOPY; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; KETOACIDOSIS; METABOLIC REGULATION; MONONEUROPATHY; MUSCLE ATROPHY; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; REVIEW; RISK FACTOR; SCREENING; SENSORIMOTOR NEUROPATHY; SENSORY ANALYSIS; SENSORY NEUROPATHY; SEXUAL DYSFUNCTION; STOMACH PARESIS; SUDDEN DEATH; TEMPERATURE SENSE; URINE RETENTION; VIBRATION SENSE; XEROSTOMIA;

AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETIC NEUROPATHIES; HUMANS;

EID: 20144389536     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.956     Document Type: Review

References (22)

1. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy (Technical Review). Diabetes Care 26:1553-1579, 2003
2. Boulton AJM, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies (Technical Review). Diabetes Care 27:1458-1486, 2004
3. Boulton AJM, Gries FA, Jervell JA: Guidelines for the diagnosis and outpatient management diabetic peripheral neuropathy. Diabet Med 15:508-514, 1998
4. Thomas PK: Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes 46 (Suppl. 2):S54-S57, 1997
5. Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, Hann AW, Hussein A, Jackson N, Johnson KE, Ryder CH, Torkington R, Van Ross ER, Whalley AM, Widdows P, Williamson S, Boulton AJM: The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 19:377-384, 2002
6. Vinik A, Mehrabyan A, Colen L, Boulton AJM: Focal entrapment neuropathies in diabetes (Review). Diabetes Care 27:1783-1788, 2004
7. Ayyar DR, Sharma KR: Chronic demyelinating polyradiculoneuropathy in diabetes. Curr Diab Rep 4:409-412, 2004
8. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D'Andrea F, D'Armiento M, Giugliano D: Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978-2984, 2004
9. Boulton AJM, Selam JL, Sweeney M, Ziegler D: Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 44:1296-1301, 2001
10. Saenz de Tejada I, Anglin G, Knight JR, Emmick JT: Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care 25:2159-2164, 2002
11. Goldstein I, Young J, Fischer J, Bangerter K, Segerson T, Taylor T, the Vardenafil Diabetes Study Group: Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care 26:777-783, 2003
12. Maleki D, Loche R, Camilleri M: Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 160:2808-2816, 2000
13. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M: Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 161:1989-1996, 2001
14. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 25:1458-1463, 2002
15. Zinman B, Ruderman N, Campaigne BN, Devlin JT, Schneider SH: Physical activity/exercise in diabetes (Position Statement). Diabetes Care 27 (Suppl. 1):S58-S62, 2004
16. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 21:114-121, 2004
17. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J: Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 52:536-541, 2003
18. Simovic D, Isner JM, Ropper AH, Pieczek A, Weinberg DH: Improvement in chronic ischemic neuropathy after intramuscular phVEGF165 gene transfer in patients with critical limb ischemia. Arch Neurol 58:761-768, 2001
19. Vinik A, Mehrabyan A: Diabetic neuropathies. Med Clin N Am 88:947-999, 2004
20. Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled trial. Pain 110:628-638, 2004
21. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, Vinik AI, the CAPSS-141 Study Group: Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 63:865-873, 2004
22. Wernicke J, Rosen AS, Lu Y, Iyengar S, Lee TC: Superiority of Duloxetine over placebo in the treatment of diabetic neuropathic pain demonostrated in two studies (Abstract). Diabetes 53 (Suppl. 2):A24, 2004